Innovation prize winner of many contests, Cardiawave was created at the end of 2014 as a result of a partnership of over 6 years between the Langevin Institute, a world leader in ultrasound imaging and therapy, and the Georges Pompidou European Hospital (HEGP), a leader in the field of valve disease and cardiac ultrasound imaging.
Led by an experienced management team with a solid background in industrial and clinical development and backed by an international SAB with Prof. Alain Cribier (inventor of TAVR), Cardiawave has secured over €8m since inception to develop and bring its medical device to the market.
A first paper was published in JACC: Basic to Translational Science in June 2017: Villemain, O., Robin, J., Bel, A., et al. Pulsed cavitational ultrasound softening: a new noninvasive therapeutic approach for calcified bioprosthetic valve stenosis, JACC: Basic to Translational Science, 2 (2017), pp. 372-383.
Awards & Honours:
2017 Prize-winner of Worldwide Innovation Contest (CMI), 3rd phase
French government / BPI France
2015 Prize-winner of Worldwide Innovation Contest (CMI), 2nd phase
French government / BPI France
2015 Prize winner of Fondation pour l’Innovation Thérapeutique Béatrice Denys
Turenne Capital (French Investment Fund)
2014 Prize-winner of Worldwide Innovation Contest (CMI), 1st phase
French government / BPI France
2014 Prize-winner of the French National Contest for Innovative Technologies Companies
French government / BPI France
Management
Board
SAB
TEAM
